Olema Pharmaceuticals, Inc. OLMA Research And Development Project Deposit Applied Against Study Invoices
Research And Development Project Deposit Applied Against Study Invoices at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept olma:ResearchAndDevelopmentProjectDepositAppliedAgainstStudyInvoices.
The official record: Olema Pharmaceuticals, Inc.’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s research and development project deposit applied against study invoices.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s research and development project deposit applied against study invoices?
- Olema Pharmaceuticals, Inc. (OLMA) reported research and development project deposit applied against study invoices of $44.25K in Q4 2025.
- How has Olema Pharmaceuticals, Inc.'s research and development project deposit applied against study invoices changed year-over-year?
- Olema Pharmaceuticals, Inc.'s research and development project deposit applied against study invoices decreased by 76.3% year-over-year, from $187K to $44.25K.
- What does research and development project deposit applied against study invoices mean?
- This represents the application of previously paid deposits against current invoices for research and development studies. It indicates the utilization of prepaid assets to offset ongoing clinical trial or preclinical research expenses. This metric helps track the burn rate and the timing of cash outflows for R&D projects.